FundraiseJun 27, 2026, 22:09 UTC

Omics-OS lands CHF 40,000 from Venture Kick to build the operating system for biology

What's the deal? Swiss startup Omics-OS has won a CHF 40,000 (≈$49,410) grant from Venture Kick to expand its agentic data platform for biotech research.

The platform makes multi-omics data accessible, harmonised, and actionable for both scientists and AI agents.

It combines an open-source multi-agent engine for bioinformatics workflows with a managed cloud workspace, letting research teams generate reproducible analyses and partner-ready data packages without coding.

Why now? Omics-OS already had a production-grade platform and its first paying customer when it entered Venture Kick. What it lacked was commercial focus and the resources to build a team.

The grant covers operational costs as both founders head to the US to raise a pre-seed round.

The company is also hiring its first interns to accelerate product validation and business development.

What could go wrong? Omics-OS still needs to convert early traction into a scalable, fundable company.

The startup sharpened its pitch, narrowing from selling its full vision to solving one urgent problem: helping biotech teams produce harmonised, auditable data packages under deadline.

Whether that focus translates into a repeatable sales process and a successful US raise remains unproven.

The signal: Venture Kick's staged grant model is designed to push early-stage Swiss founders towards commercial focus, and Omics-OS is a textbook case — the program prompted it to narrow from selling a sweeping "operating system for biology" vision to solving one urgent, billable problem. With both founders now heading to the US for a pre-seed raise, the CHF 40,000 is less about runway than about validating whether that sharpened, agentic-data positioning can win in a market where AI-native bioinformatics players are racing to define the layer between scientists and their data.